Paul Evans was featured in Applied Clinical Trials‘ latest article weighing in on the real-world implications of recent executive orders affecting DEI initiatives nationwide.
In the piece, Paul underscores Velocity’s unwavering commitment to inclusive, patient-centered research environments, stating:
“Velocity believes that clinical trials should be a safe space for the entire LGBT community… It’s important that all members of the LGBT community feel welcome, regardless of their specific identities. If participants feel excluded or unwelcome, it could affect the broader community’s trust.”
He also shared how Velocity continues to foster diversity without quotas — by actively hiring teams reflective of the communities we serve and building trust through genuine engagement.
As legislation evolves, ensuring clinical trials remain accessible, inclusive, and representative is more important than ever for advancing equitable care.
Read the full article and Paul’s perspective here: https://www.appliedclinicaltrialsonline.com/view/the-impact-of-dei-ban-on-clinical-research-ecosystem
